Hippocampal drug delivery devices and methods
AssigneeAlcyone Lifesciences, Inc.
InventorsEric Leuthardt, P J Anand
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlcyone Lifesciences, Inc.
InventorsEric Leuthardt, P J Anand
Estimating the term…
Drug delivery devices and methods are disclosed herein. In some embodiments, a drug can be delivered into a brain ventricle of a subject, where it can diffuse, flow, or otherwise travel across the ependyma and into the hippocampus. The drug can be delivered through a delivery device configured to selectively or transiently obstruct a portion of the ventricle, e.g., the temporal horn or a posterior portion of the temporal horn. The obstruction can define a partitioned volume of the ventricle, limiting or preventing flow of cerebrospinal fluid (CSF) into or out of the partitioned volume. Accordingly, a drug can be delivered into the partitioned volume without being diluted or carried away by CSF, allowing the drug to saturate the ependyma adjacent the hippocampus. The delivery device can allow a high concentration of drug to be achieved and/or maintained within the partitioned volume to enable maximal transependymal penetration to the hippocampus, while reducing the volume of drug needed to achieve a desired therapeutic effect and limiting delivery of the drug to non-targeted areas.
A drug delivery method, comprising:
A drug delivery method, comprising:
A drug delivery method, comprising:
A drug delivery method, comprising:
Dependencies are inferred from the claim text.